[Intralymphatic administration of estramustine phosphate].
Sakamoto
H
H
Department of Obstetrics and Gynecology, Nihon University School of Medicine, Tokyo.
Ohtani
K
K
Kawamori
J
J
Shirakawa
T
T
Ohta
H
H
Igarashi
N
N
Tochigi
M
M
Furuya
K
K
Tsubata
K
K
Tanaka
Y
Y
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage* / Q000493:pharmacokinetics; D004961:Estramustine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D007272:Injections, Intralymphatic; D008207:Lymphatic Metastasis; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology
D018931:Antineoplastic Agents, Hormonal; D004961:Estramustine